000 | 01855 a2200577 4500 | ||
---|---|---|---|
005 | 20250513170030.0 | ||
264 | 0 | _c19990316 | |
008 | 199903s 0 0 eng d | ||
022 | _a0022-2623 | ||
024 | 7 |
_a10.1021/jm980569z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChambers, M S | |
245 | 0 | 0 |
_a3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents. _h[electronic resource] |
260 |
_bJournal of medicinal chemistry _cFeb 1999 |
||
300 |
_a691-705 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 | _aCHO Cells |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 |
_aIndoles _xchemical synthesis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMigraine Disorders _xdrug therapy |
650 | 0 | 4 | _aModels, Molecular |
650 | 0 | 4 |
_aPiperazines _xchemical synthesis |
650 | 0 | 4 | _aRadioligand Assay |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1B |
650 | 0 | 4 | _aReceptor, Serotonin, 5-HT1D |
650 | 0 | 4 |
_aReceptors, Serotonin _xdrug effects |
650 | 0 | 4 |
_aRecombinant Proteins _xagonists |
650 | 0 | 4 |
_aSerotonin Receptor Agonists _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aStreet, L J | |
700 | 1 | _aGoodacre, S | |
700 | 1 | _aHobbs, S C | |
700 | 1 | _aHunt, P | |
700 | 1 | _aJelley, R A | |
700 | 1 | _aMatassa, V G | |
700 | 1 | _aReeve, A J | |
700 | 1 | _aSternfeld, F | |
700 | 1 | _aBeer, M S | |
700 | 1 | _aStanton, J A | |
700 | 1 | _aRathbone, D | |
700 | 1 | _aWatt, A P | |
700 | 1 | _aMacLeod, A M | |
773 | 0 |
_tJournal of medicinal chemistry _gvol. 42 _gno. 4 _gp. 691-705 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm980569z _zAvailable from publisher's website |
999 |
_c10013487 _d10013487 |